Prourokinase (Erbamont)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameProurokinase (Erbamont)

Drug Alias NamePUK (Erbamont)Pro-urokinase (Erbamont)FCE-27485

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionFibrinolysis stimulants

TargetsNot applicable

Therapy Area/IndicationsVenous ThrombosisMyocardial InfarctionPulmonary Embolism

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsVenous ThrombosisMyocardial InfarctionPulmonary Embolism

ATC CodeN/A